Vertex Pharmaceuticals (LTS:0QZU) FCF Margin % : 46.97% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Vertex Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vertex Pharmaceuticals's Free Cash Flow for the three months ended in Sep. 2024 was $1,302 Mil. Vertex Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was $2,772 Mil. Therefore, Vertex Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2024 was 46.97%.

As of today, Vertex Pharmaceuticals's current FCF Yield % is -1.12%.

The historical rank and industry rank for Vertex Pharmaceuticals's FCF Margin % or its related term are showing as below:

LTS:0QZU' s FCF Margin % Range Over the Past 10 Years
Min: -107.56 Med: 32.51 Max: 48.24
Current: -12.72

During the past 13 years, the highest FCF Margin % of Vertex Pharmaceuticals was 48.24%. The lowest was -107.56%. And the median was 32.51%.

LTS:0QZU's FCF Margin % is ranked better than
70.05% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs LTS:0QZU: -12.72

Vertex Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Vertex Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals FCF Margin % Chart

Vertex Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

35.89

48.24

31.80

43.95

33.22

Vertex Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															49.44	4.71	39.33	-144.78	46.97

Competitive Comparison of Vertex Pharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Vertex Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vertex Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vertex Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vertex Pharmaceuticals's FCF Margin % falls into.

Vertex Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vertex Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	3278.9	/	9869.2
	=	33.22 %

Vertex Pharmaceuticals's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	1302.1	/	2771.9
	=	46.97 %

Vertex Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vertex Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vertex Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (LTS:0QZU) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

VRTX:USA VRTX:Mexico 1VRTX:Italy VX1:Germany VX1:Germany VX1:Germany VRTX34:Brazil VRTX:Austria

Address

50 Northern Avenue, Boston, MA, USA, 02210

Website

https://www.vrtx.com

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Vertex Pharmaceuticals Headlines

No Headlines